Neumann Diagnostics February 09, 2016

GenomeWeb’s in-depth story on NEUMANN

GenomeWeb published an in-depth article about NEUMANN:

Hungary’s Neumann Diagnostics Readies HPV, Cervical Cancer Risk Test for European Market

The company’s Confidence assays are designed to detect if a woman has a high-risk HPV subtype and, if so, determine her risk of developing cervical pre-cancer or cancer.